Cellares has secured a $50 million growth equity investment from [...]

VIVEbiotech has expanded its in vivo lentiviral vector portfolio to [...]

Countable Labs has raised $26 million in an oversubscribed financing [...]

Scaling production of adeno-associated virus vectors remains a key barrier [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Sartorius has launched a new platform designed to address manufacturing [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

SynGenSys has launched Liver.SET, a library of liver-specific synthetic promoters [...]

NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

eXmoor Pharma has formed a strategic collaboration with University College [...]